129 related articles for article (PubMed ID: 11805220)
1. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.
Kolasa T; Gunn DE; Bhatia P; Basha A; Craig RA; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
J Med Chem; 2000 Aug; 43(17):3322-34. PubMed ID: 10966751
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
Penning TD; Chandrakumar NS; Chen BB; Chen HY; Desai BN; Djuric SW; Docter SH; Gasiecki AF; Haack RA; Miyashiro JM; Russell MA; Yu SS; Corley DG; Durley RC; Kilpatrick BF; Parnas BL; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Krivi GG; Villani-Price D; Pyla EY; Smith WG
J Med Chem; 2000 Feb; 43(4):721-35. PubMed ID: 10691697
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.
Whittle BJ; Varga C; Berko A; Horvath K; Posa A; Riley JP; Lundeen KA; Fourie AM; Dunford PJ
Br J Pharmacol; 2008 Mar; 153(5):983-91. PubMed ID: 18157165
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid activates phospholipase D in human neutrophils; essential role of endogenous leukotriene B4 and inhibition by adenosine A2A receptor engagement.
Grenier S; Flamand N; Pelletier J; Naccache PH; Borgeat P; Bourgoin SG
J Leukoc Biol; 2003 Apr; 73(4):530-9. PubMed ID: 12660228
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
Yuan JH; Birkmeier J; Yang DC; Hribar JD; Liu N; Bible R; Hajdu E; Rock M; Schoenhard G
Drug Metab Dispos; 1996 Oct; 24(10):1124-33. PubMed ID: 8894515
[TBL] [Abstract][Full Text] [Related]
11. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
Appiah-Kubi P; Soliman ME
J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
[TBL] [Abstract][Full Text] [Related]
12. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
13. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
Surette ME; Krump E; Picard S; Borgeat P
Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene A4 hydrolase: identification of a common carboxylate recognition site for the epoxide hydrolase and aminopeptidase substrates.
Rudberg PC; Tholander F; Andberg M; Thunnissen MM; Haeggström JZ
J Biol Chem; 2004 Jun; 279(26):27376-82. PubMed ID: 15078870
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 5-lipoxygenase inhibitors in biochemical and functional in vivo assays.
Smith WG; Shaffer AF; Currie JL; Thompson JM; Kim S; Rao T; Isakson PC
J Pharmacol Exp Ther; 1995 Dec; 275(3):1332-8. PubMed ID: 8531100
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.
Penning TD
Curr Pharm Des; 2001 Feb; 7(3):163-79. PubMed ID: 11311111
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
[TBL] [Abstract][Full Text] [Related]
19. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
Sonawane LV; Bari SB
Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
